Carmelo Caldarella

Born in Augusta (SR) on 02/06/1982

Degree in Medicine and Surgery obtained at the Catholic University of the Sacred Heart - Rome branch on 25/07/2007 (score 110/110 with honors) with a thesis on cerebral perfusion SPECT before and after pharmacological epileptogenic stimulus in patients with partial epilepsy with a view to surgical treatment

Specialization in Nuclear Medicine obtained at the Catholic University of the Sacred Heart - Rome branch on 12/04/2012 (score 50/50 with honors) with a thesis on parathyroid scintigraphy with MIBI in patients with secondary hyperparathyroidism.

Full-time and permanent Medical Director in the discipline of Nuclear Medicine (specialist position) at the Fondazione Policlinico Universitario "A. Gemelli" IRCCS from 01/02/2013 to date; the work activity is carried out at the PET-CT Center of the same facility, in particular reporting of PET-CT exams with FDG in patients with neoplastic or neuro-degenerative pathology, with fluoro-choline in patients with hyperparathyroidism and with fluoro-choline or PSMA in patients with prostatic neoplasia.

Research activity in the same fields mentioned above, with particular interest in multiple myeloma and prostate cancer, with at least 54 publications in extensive journals and numerous congress abstracts and oral communications at national and international congresses.

Teaching activity at the University of the Biomedical Campus of Rome from 2020 to today in the Degree Course in Medical Radiology Techniques.

Teaching activity at the Catholic University of the Sacred Heart of Rome (Faculty of Medicine and Surgery "A. Gemelli") from 2021 to today in the Degree Course in Medicine & Surgery (teaching in English),

54 publications in full (last 4 years)

Pizzuto DA et al. 18F-Fluoroethylcholine PET/CT Radiomic Analysis for Newly Diagnosed Prostate Cancer Patients: A Monocentric Study. Int J Mol Sci. 2022 Aug 14;23(16):9120.

Taralli S et al. Adenoid cystic carcinoma of the parotid gland: a first case report on 11 C-methionine PET/CT detection of histologically confirmed pulmonary metastases. Acta Oncol. 2022 Jun;61(6):669-671.

Taralli S et al. The Prognostic Value of 18 F-FDG PET Imaging at Staging in Patients with Malignant Pleural Mesothelioma: A Literature Review. J Clin Med. 2021 Dec 22;11(1):33.

Caldarella C et al. The impact of the COVID-19 pandemic on oncological disease extent at FDG PET/CT staging: the ONCOVIPET study. Eur J Nucl Med Mol Imaging. 2021 Dec 8:1-7.

Taralli S et al.Bone Marrow Activation After Chemotherapy Presenting as Diffuse Skeletal Uptake on 18F-Fluorocholine PET/CT. Clin Nucl Med. 2021 Oct 1;46(10):e498-e500.

Ripani D et al. Progression to Symptomatic Multiple Myeloma Predicted by Texture Analysis-Derived Parameters in Patients Without Focal Disease at 18 F-FDG PET/CT. Clin Lymphoma Myeloma Leuk. 2021 Aug;21(8):536-544.

Biscontini G et al. 18F-Fluciclovine Positron Emission Tomography in Prostate Cancer: A Systematic Review and Diagnostic Meta-Analysis. Diagnostics. 2021 Feb;11(2):304.

Maccora D et al. Diagnostic role of 11C-methionine PET/CT in patients with multiple myeloma and other plasma cell malignancy: a literature review. Clin Transl Imaging. 2021 Jan; 9:3-17.

Maccora D et al. 11C-Methionine PET/CT in patients with primary hyperparathyroidism and inconclusive pre-operative imaging work-up: diagnostic accuracy and role of semi-quantitative analysis. Ann Nucl Med. 2021 Jan; 35:469-478.

Maccora D et al. Incidental Finding of an Ovarian Carcinoid on 11C-Methionine PET/CT. Clin Nucl Med. 2020 Nov;45(11):e483-e485.

Lorusso M et al. Radiolabelled Trastuzumab PET/CT imaging: a promising non-invasive tool for the in vivo assessment of HER2 status in breast cancer patients. Clin Transl Imaging. 2020 Mar;8:95-105.

Taralli S et al. Comparison between 18F-FDG and 18F-NaF PET imaging for assessing bone metastases in breast cancer patients: a literature review. Clin Transl Imaging. 2020 Mar;8:65-78.

Minordi LM et al. A Case of Primary Localized Small Bowel Amyloidosis Studied by 18F-Choline and Contrast-Enhanced 18F-FDG PET/CT. Clin Nucl Med. 2020 Mar;45(3):e154-e155.

Belmonte G et al. Muscle Recurrence of a Primarily Nodal Follicular Lymphoma Studied by Contrast-Enhanced 18F-FDG PET/CT. Clin Nucl Med. 2020 Jan;45(1):65-67.

Ripani D et al. Prognostic significance of normalized FDG-PET parameters in patients with multiple myeloma undergoing induction chemotherapy and autologous hematopoietic stem cell transplantation: a retrospective single-center evaluation. Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):116-128.

Pizzuto DA et al. Lung uptake of fluorine-18 fluoroethyl-choline PET-CT in patients with prostate cancer. QJ Nucl Med Mol Imaging. 2019 Dec;63(4):387-393.